Introduction
Distal renal tubular acidosis is associated with inadequate urinary acidification by the distal nephron. Patients usually present with a urine pH greater than 5.5 despite their hyperchloremic metabolic acidosis [1•]. Complications of distal renal tubular acidosis (dRTA) in children include failure to thrive, growth retardation, osteopenia, and rickets. Increased urinary calcium excretion and decreased urinary citrate excretion often result in nephrolithiasis or nephrocalcinosis [1•], which can lead to urinary concentration defects and ultimately chronic renal insufficiency [2•]. The plasma anion gap (Na + − [Cl − + HCO 3 − ]) is normal, but the urinary anion gap is usually positive (urine anion gap = Na + + K + − Cl − ) because of a decrease in NH 4 + excretion [•1]. Fractional K + excretion is usually increased with normal or low plasma K + [•1].
Inherited dRTA includes both autosomal dominant and autosomal recessive modes. Autosomal recessive dRTA often presents in infancy, whereas autosomal dominant dRTA may not present until adolescence or young adulthood [3••] . Some patients with autosomal recessive dRTA have associated sensorineural hearing loss. Mutations in the genes encoding carbonic anhydrase (CA) II, kidney anion exchanger 1 (kAE1), and subunits of the H + -ATPase have been identified in patients with dRTA. Figure 1 shows the mechanism of H + secretion by the type A intercalated cell in the distal nephron. The Aintercalated cell secretes H + via the luminal H + -ATPase and H + / K + -ATPase, although the latter is regulated for K + homeostasis. CA IV on the brush border of the cell converts luminal HCO 3 − and the secreted H + into H 2 O and CO 2, some of which diffuses back into the cell. Cytosolic CA II facilitates the conversion of CO 2 and H 2 O to HCO 3 − and H + , allowing more protons for secretion via the ATPases. Cellular HCO 3 − is absorbed via the basolateral Cl − /HCO 3 − exchanger (kAE1). Overall, H + secretion by the A-intercalated cell allows for HCO 3 − to be reabsorbed and net acid to be secreted along the collecting duct, and a defect of any of these components may lead to dRTA.
Figure 1 also depicts HCO 3
− reabsorption by the proximal tubule cell. Defects in CA or the transporters may lead to proximal or type 2 RTA. Patients with proximal RTA can be differentiated from those with dRTA by certain laboratory studies. The urinary anion gap is usu-ally negative and urine pH is less than 5.5 [1•]. The excretion of NH 4 + , calcium, and citrate are normal and nephrocalcinosis/lithiasis is usually absent [1•]. The fractional excretion of K + can be increased or normal, resulting in a normal or decreased plasma K + . Other proximal tubule defects are often present. After correction of the reduced serum HCO 3 − concentration, the fractional excretion of HCO 3 − by proximal RTA patients is greater than 10 to 15%, whereas in patients with dRTA it is less than 5% [1•].
Type 4 or hyperkalemic RTA accompanies a large number of hyperkalemic states and is most frequently observed in states of hypo-or pseudohypoaldosteronism [1•]. Plasma K + is increased and the fractional excretion of K + is decreased. Although the urine pH is less than 5.5, the urinary anion gap is positive because of the low rate of NH 4 + excretion [1•]. The fractional excretion of bicarbonate after alkali loading is greater than 5 to 10% [1•]. Calcium excretion is normal or decreased, and the excretion of citrate is normal, resulting in the absence of nephrocalcinosis/lithiasis [1•].
Distal renal tubular acidosis

Carbonic anhydrase II mutations Guibaud-Vainsel syndrome
Guibaud-Vainsel syndrome, or marble brain disease, is an autosomal recessive cause of CA II deficiency. Affected children often have a mixed proximal and distal RTA, but either can predominate [4, 5] . This syndrome is characterized by osteopetrosis with increased bone density on radiograph but with fragile bones that are prone to fractures. There may be growth failure, facial dysmorphism, intracerebral calcifications, mental retardation, blindness, and conductive hearing loss. Previously, 16 different CA II mutations have been identified to cause Guibaud-Vainsel syndrome [6, 7] . Borthwick et al. [8••] investigated two consanguineous kindreds from Turkey and found one to harbor a novel mutation and the other to have two separate recessive disorders leading to the coexistence of osteopetrosis and dRTA. The first kindred had a homozygous deletion resulting in a premature termination of the CA II gene and very low levels of CA II in the erythrocytes of affected children. The second kindred had normal CA II erythrocyte activity, but was homozygous for mutations in two different subunits of the H + -ATPase, the B1 subunit (discussed below) and the osteoclast-specific isoform of the "a" subunit. This mutation results in isolated recessive malignant osteopetrosis [9, 10] . kAE1 mutations AE1 exists as a mixture of dimers and tetramers in the basolateral cell membrane of A-intercalated cells [11] . Several mutations of the AE1 gene are associated with the autosomal dominant form of dRTA [12] [13] [14] [15] [16] , and two have been identified to cause autosomal recessive dRTA [17, 18] . The autosomal dominant mutations are found often in Western populations but are probably worldwide
The kidney AE1 (kAE1) and the erythrocyte AE1 (eAE1) proteins are both transcribed from the same gene but have different promoters. The kAE1 protein lacks the 65 amino acids present on the N-terminal tail of eAE1. The function of eAE1 is usually not significantly altered by mutations that cause dRTA, and other mutations, which result in alterations in the RBC phenotype, are not usually associated with dRTA. kAE1 901 stop A 901 stop mutation was identified in two brothers with autosomal dominant dRTA [20••] . In this mutation, one of the AE1 genes results in a premature stop codon and a deletion of the last 11 residues of the C-terminus. The mutated AE1 is not grossly misfolded or targeted for rapid degradation. When transfected into two different kidney cell lines, there was intracellular retention of the mutant AE1 with impaired trafficking to the plasma membrane [20••]. Coexpression of kAE1 wild-type with the kAE1 901 stop mutant resulted in intracellular retention of both proteins; the kAE1 901 stop mutant interacts with wild-type proteins in transfected cells, probably as heterodimers. The hetero-oligomer formation of the mutant and the wild-type AE1 proteins explains the dominant negative effect [20••].
When AE1 ⌬11 was transfected into two polarized kidney cell lines, the mutant protein was located not only basolaterally but also apically and intracellularly [19••] . Intracellular retention was increased if the cells were not fully polarized. This suggests that the loss of epithelial polarity can cause intracellular retention of some proteins that normally reside on the plasma membrane [19••]. These and other data indicate that a tyrosine-based motif in the C-terminus of AE1 plays a key role in the polarized distribution of AE1 at the cell surface, and that its absence is associated with autosomal dominant dRTA [19••] . Loss of polarized trafficking of AE1 may be the primary cause of dysfunction of the A-intercalated cells in autosomal dominant dRTA.
Band 3 Walton
Band 3 Walton mutation also results in the deletion of the 11 C-terminal amino acids of the AE1 protein and autosomal dominant dRTA [21••] . Although this mutation does not affect anion transport activity when expressed in erythrocytes and oocytes, it inhibits the trafficking of the anion exchanger to the plasma membrane of Madin-Darby canine kidney cells. In two brothers with dRTA and this mutation, there was no physiologic abnormality of their erythrocytes [21••]. Again, the tyrosine deleted in this mutation is thought to be important for intracellular sorting and basolateral targeting [22, 23] .
R589, S613
Missense mutations (R589H, R589C, R589S, and S613F) associated with autosomal dominant dRTA have been expressed in Xenopus oocytes [15, 24] . Anion exchange was functional with either the kAE1 or eAE1 mutant, suggesting that the cause of the dRTA is mistargeting of kAE1 [24] . This would account for the impaired kidney but normal red blood cell anion-transport function. Quilty et al. tested this hypothesis by transfecting HEK-293 (human embryonic kidney) cells with AE1, AE1 R589H, kAE1, and kAE1 R589H. All forms were identified on the cell surface except for the kAE1 R589H mutant, which was located intracellularly [25••]. Coexpression of kAE1 R589H with either kAE1 or eAE1 led to heterodimer formation of the two proteins and, by a dominant-negative effect, reduced cell surface expression of either kAE1 or the eAE1. Neither kAE1 nor eAE1 R589H mutants were grossly misfolded [25••]. Similar defective trafficking is observed with mutants R589C and R589S [25•,26] . Because all three mutations of the R589 result in improper trafficking, it is likely that this conserved arginine (R) is essential for proper trafficking of kAE1 to the surface of epithelial cells [25••] . The third intracellular loop of AE1 contains six basic residues (R589 is one of them), which are highly conserved in known AE1, AE2, and AE3 sequences and may create a motif for proper trafficking [25••]. It is not known why eAE1 is not affected to the same extent as kAE1.
G701
G701D is a mutation of the AE1 gene associated with autosomal recessive dRTA and is a relatively common molecular defect causing dRTA in Thai children [3••].
There is impaired trafficking of eAE1 and kAE1 that can be rescued by coexpression of the red blood cell protein glycophorin A [17] . Because glycophorin A is not expressed by A-intercalated cells, the result is dRTA with a normal erythrocyte phenotype in affected patients.
H + -ATPase mutations
H + -ATPase is located on the apical membrane of Aintercalated cells, and mutations of some of its subunits have also been identified as causing dRTA. Several of the 13 subunits of the H + -ATPase proton pump have multiple isoforms expressed by separate genes with differing tissue expression patterns [27••,28] . The different subunit isoforms may determine the localization and activity of these pumps. The H + -ATPase expressed in Aintercalated cells contains the B1 and a4 subunits, of which known mutations result in dRTA [12,27••,28] . Smith et al. have shown via reverse transcription polymerase chain reaction of human tissues that the C2, d2, and G3 isoforms are expressed in kidney and few other tissues [27••] . These isoforms may in the future present additional dRTA loci, because a number of autosomal recessive families with dRTA do not show a linkage to either B1 or a4. To date, no potential disease-causing mutations of the genes encoding the isoforms C2, d2, or G3 have been identified [27••].
B1 subunit of H + -ATPase
At least 15 different mutations of the B1 subunit of the H + -ATPase result in autosomal recessive dRTA [29•]. Patients with these mutations are usually located in Western populations and the Middle East [30] . Progressive sensorineural hearing loss, beginning in childhood, is associated with these mutations. In addition to the A-intercalated cell, the B1 subunit is also expressed in the inner ear [30] ; acidification of the endolymph is considered critical for normal cochlear and hair cell function. Ruf et al. [31•] examined the mutations of 15 families and identified six potential loss-of-function mutations of the gene encoding the B1 subunit in eight and an association with sensorineural hearing loss in all but one. V0 subunit, a4 Eight different mutations in the gene encoding the V0a4 subunit have been associated with recessive dRTA but with normal hearing [12] . Most patients are from the Middle East and are products of consanguineous unions [12, 32] . At least 16 additional novel mutations have been identified in a follow-up study [33••] . Several affected patients have developed mild-to-moderate sensorineural hearing loss in young adulthood [33••] . This is supported by reverse transcription polymerase chain reaction studies showing that the V0a4 subunit is expressed in the cochlea [33••] , in addition to the Aintercalated cells of the kidney.
Kcc4 mutations K + /Cl − Cotransporter, Kcc4
Boettger et al. [34••] have shown that Kcc4 knockout mice have a compensated metabolic acidosis with significantly decreased base excess. Interestingly, the knockout mice in this study were found to have sensorineural hearing loss as well, because of the degeneration of the hair cells. In the kidney, Kcc4 normally is expressed in the basolateral membrane of A-intercalated cells, suggesting that Kcc4 is required for basolateral Cl − extrusion. A rise in [Cl − ] i predicts a more alkaline intracellular pH in the knockout mice, resulting in decreased apical H + secretion because of increases in the electrochemical gradient against which H + pumping occurs [34••] . Although not yet identified in patients with dRTA, mutations in the Kcc4 gene could be a cause of recessive dRTA in humans.
ClC-5 mutations
Dent's disease is a proximal tubule disorder characterized by low molecular weight proteinuria, and may be associated with hypercalciuria, nephrocalcinosis, and renal failure; urinary acidification defects may also be seen [35] [36] [37] . The cause is an inactivating mutation of the renal chloride channel, ClC-5, which colocalizes with the H + -ATPase in proximal tubule cells and in Aintercalated cells [38, 39] . Moulin et al. [40• ] studied renal biopsies from eight patients with Dent's disease and found that the H + -ATPase in proximal tubular cells had a reverse polarity (located basolaterally rather than apically), which would account for the proximal tubular dysfunction. This study also showed that there was not any detectable staining of H + -ATPase in A-intercalated cells, which may account for clinical dRTA in some patients with Dent's disease. A loss of ClC-5 function might prevent dissipation of the H + -secretory current in endosomal vesicles, resulting in impaired endosomal acidification and function, and inefficient plasma membrane insertion and recycling of vesicles containing H + pumps [39,40•,41,42] . However, all of the patients examined had normal acid-base status at the time of biopsy. Unfortunately, NH 4 Cl loading was not performed in these patients to diagnose dRTA. In other cases of Dent's disease, as many as half of the patients have incomplete dRTA, manifested by abnormal minimum urinary pH after NH 4 Cl loading in the absence of systemic acidosis [35] .
Conclusion
Studies in this paper emphasize the importance of CAII, kAE1, and H + -ATPase in distal tubule urine acidification. Although much has been learned about different mutations of these proteins and their effects on systemic acid-base status, ongoing research shows that there is still more to learn. The future may prove to show that other genes, such as those encoding the Kcc4 cotransporter, the ClC-5, or other subunits of the H + -ATPase, may be involved in dRTA in humans. The examination of rare genetic causes of dRTA, such as those reviewed in this review, may prove invaluable in our understanding of normal and abnormal physiology and may lead to future therapeutic modalities for the more common causes of dRTA.
